| AIF deficiency compromises oxidative phosphorylation N Vahsen, C Candé, JJ Brière, P Bénit, N Joza, N Larochette, ... The EMBO journal 23 (23), 4679-4689, 2004 | 730 | 2004 |
| High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the MOSCATO 01 trial C Massard, S Michiels, C Ferté, MC Le Deley, L Lacroix, A Hollebecque, ... Cancer discovery 7 (6), 586-595, 2017 | 662 | 2017 |
| Gene expression profiling of primary cutaneous melanoma and clinical outcome V Winnepenninckx, V Lazar, S Michiels, P Dessen, M Stas, SR Alonso, ... Journal of the National Cancer Institute 98 (7), 472-482, 2006 | 548 | 2006 |
| Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials M Schwaederle, M Zhao, JJ Lee, AM Eggermont, RL Schilsky, ... Journal of clinical oncology 33 (32), 3817, 2015 | 479 | 2015 |
| Expression of the Na+/I− Symporter Gene in Human Thyroid Tumors: A Comparison Study with Other Thyroid-Specific Genes V Lazar, JM Bidart, B Caillou, C Mahé, L Lacroix, S Filetti, ... The Journal of Clinical Endocrinology & Metabolism 84 (9), 3228-3234, 1999 | 449 | 1999 |
| An immunosurveillance mechanism controls cancer cell ploidy L Senovilla, I Vitale, I Martins, M Tailler, C Pailleret, M Michaud, L Galluzzi, ... Science 337 (6102), 1678-1684, 2012 | 438 | 2012 |
| Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial J Rodon, JC Soria, R Berger, WH Miller, E Rubin, A Kugel, A Tsimberidou, ... Nature medicine 25 (5), 751-758, 2019 | 429 | 2019 |
| Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array F Andre, B Job, P Dessen, A Tordai, S Michiels, C Liedtke, C Richon, ... Clinical cancer research 15 (2), 441-451, 2009 | 367 | 2009 |
| Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects C Borg, M Terme, J Taïeb, C Ménard, C Flament, C Robert, K Maruyama, ... The journal of clinical investigation 114 (3), 379-388, 2004 | 360 | 2004 |
| miR-181a and miR-630 regulate cisplatin-induced cancer cell death L Galluzzi, E Morselli, I Vitale, O Kepp, L Senovilla, A Criollo, N Servant, ... Cancer research 70 (5), 1793-1803, 2010 | 339 | 2010 |
| Association of biomarker-based treatment strategies with response rates and progression-free survival in refractory malignant neoplasms: a meta-analysis M Schwaederle, M Zhao, JJ Lee, V Lazar, B Leyland-Jones, RL Schilsky, ... JAMA oncology 2 (11), 1452-1459, 2016 | 333 | 2016 |
| αEβ7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis AL Floc'h, A Jalil, I Vergnon, BLM Chansac, V Lazar, G Bismuth, ... The Journal of experimental medicine 204 (3), 559-570, 2007 | 305 | 2007 |
| High expression of DNA repair pathways is associated with metastasis in melanoma patients A Kauffmann, F Rosselli, V Lazar, V Winnepenninckx, A Mansuet-Lupo, ... Oncogene 27 (5), 565-573, 2008 | 277 | 2008 |
| Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins N de Parseval, V Lazar, JF Casella, L Benit, T Heidmann Journal of virology 77 (19), 10414-10422, 2003 | 272 | 2003 |
| Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas S Puget, C Philippe, DA Bax, B Job, P Varlet, MP Junier, F Andreiuolo, ... PloS one 7 (2), e30313, 2012 | 261 | 2012 |
| Apoptosis regulation in tetraploid cancer cells M Castedo, A Coquelle, S Vivet, I Vitale, A Kauffmann, P Dessen, ... The EMBO journal 25 (11), 2584-2595, 2006 | 233 | 2006 |
| FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase S Fabre, F Carrette, J Chen, V Lang, M Semichon, C Denoyelle, V Lazar, ... The Journal of Immunology 181 (5), 2980-2989, 2008 | 225 | 2008 |
| Simple sequence repeat polymorphism within the p53 gene. V Lazar, F Hazard, F Bertin, N Janin, D Bellet, B Bressac Oncogene 8 (6), 1703-1705, 1993 | 224 | 1993 |
| Impact of a biomarker-based strategy on oncology drug development: a meta-analysis of clinical trials leading to FDA approval DL Fontes Jardim, M Schwaederle, C Wei, JJ Lee, DS Hong, ... Journal of the National Cancer Institute 107 (11), djv253, 2015 | 198 | 2015 |
| Expression of Pendrin and the Pendred Syndrome (PDS) Gene in Human Thyroid Tissues JM Bidart, C Mian, V Lazar, D Russo, S Filetti, B Caillou, M Schlumberger The Journal of Clinical Endocrinology & Metabolism 85 (5), 2028-2033, 2000 | 189 | 2000 |
